+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-08-31Number of Pages: 156

Pharmaceutical Products and CMO Market: (Product Type - API and Ingredients, Finished Dosage Form, and Pharmaceutical Packaging) - LATAM Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Section 1 Preface 
1.1 Report Scope 
1.2 Research Objective 

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview 
4.1 Product Overview 
4.2 Key Industry Developments
4.3 Contract Manufacturing Regulations 

Section 5 Market Dynamics
5.1 Drivers – Pharmaceutical Products Market
5.2 Restraints – Pharmaceutical Products Market
5.3 Opportunities – Pharmaceutical Products Market 
5.4 Drivers – CMO Market
5.5 Restraints – CMO Market
5.6 Opportunities – CMO Market 
5.7 Opportunity Analysis
5.8 Porter’s Analysis 
5.9 Value Chain Analysis

Section 6 LATAM Pharmaceutical Products and CMO Market Analysis, by Product Type 
6.1 Key Findings
6.2 Introduction 
6.3 LATAM Pharmaceutical Products Market Value Share Analysis By Product Type, 2015 and 2024
6.4 LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast By Product Type, 2014–2024
6.5 LATAM Pharmaceutical Products Market Analysis, by Product Type (1/7)
6.6 LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product Type
6.7 LATAM CMO Market Size (US$ Mn) Forecast By Product Type, 2014–2024
6.8 Latin America CMO Market Value Share Analysis By Product Type, 2015 and 2024
6.9 LATAM CMO Market Analysis, by Product Type 
6.10 LATAM CMO Market Attractiveness Analysis, by Product Type
6.11 Key Trends

Section 7 LATAM Pharmaceutical Products and CMO Market Analysis, by Country 
7.1 Latin America Pharmaceutical Products Market Value Share Analysis, by Country
7.2 Pharmaceutical Products Market Forecast, by Country
7.3 Pharmaceutical Products Market Attractiveness Analysis, by Country, 2015
7.4 Latin America CMO Market Value Share Analysis, by Country, 2015 and 2024
7.5 Latin America CMO Market Forecast, by Country

Section 8 Mexico Pharmaceutical Products and CMO Market Analysis
8.1 Key Findings
8.2 Mexico Pharmaceutical Products Market Overview
8.3 Mexico Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
8.4 Mexico Market Forecast, by Product
8.5 Mexico Market Attractiveness Analysis
8.6 Mexico CMO Market Overview
8.7 Mexico CMO Market Value Share Analysis, by Product, 2015 and 2024
8.8 Mexico CMO Market Forecast, by Product
8.9 Mexico CMO Market Attractiveness Analysis, by Product, 2015
8.10 Market Trends

Section 9 Brazil Pharmaceutical Products and CMO Market Analysis
9.1 Key Findings
9.2 Brazil Pharmaceutical Products Market Overview
9.3 Brazil Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
9.4 Brazil Market Forecast, by Product
9.5 Brazil Market Attractiveness Analysis
9.6 Brazil CMO Market Overview
9.7 Brazil CMO Market Value Share Analysis, by Product, 2015 and 2024
9.8 Brazil CMO Market Forecast, by Product
9.9 Brazil CMO Market Attractiveness Analysis, by Product, 2015
9.10 Market Trends

Section 10 Venezuela Pharmaceutical Products and CMO Market Analysis
10.1 Key Findings
10.2 Venezuela Pharmaceutical Products Market Overview
10.3 Venezuela Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
10.4 Venezuela Market Forecast, by Product
10.5 Venezuela Market Attractiveness Analysis
10.6 Venezuela CMO Market Overview
10.7 Venezuela CMO Market Value Share Analysis, by Product, 2015 and 2024
10.8 Venezuela CMO Market Forecast, by Product
10.9 Venezuela CMO Market Attractiveness Analysis, by Product, 2015
10.10 Market Trends

Section 11 Argentina Pharmaceutical Products and CMO Market Analysis
11.1 Key Findings
11.2 Argentina Pharmaceutical Products Market Overview
11.3 Argentina Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
11.4 Argentina Market Forecast, by Product
11.5 Argentina Market Attractiveness Analysis
11.6 Argentina CMO Market Overview
11.7 Argentina CMO Market Value Share Analysis, by Product, 2015 and 2024
11.8 Argentina CMO Market Forecast, by Product
11.9 Argentina CMO Market Attractiveness Analysis, by Product, 2015
11.10 Market Trends

Section 12 Rest of Latin America Pharmaceutical Products and CMO Market Analysis
12.1 Key Findings
12.2 Rest of Latin America Pharmaceutical Products Market Overview
12.3 Rest of Latin America Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
12.4 Rest of Latin America Market Forecast, by Product
12.5 Rest of Latin America Market Attractiveness Analysis
12.6 Rest of Latin America CMO Market Overview
12.7 Rest of Latin America CMO Market Value Share Analysis, by Product, 2015 and 2024
12.8 Rest of Latin America CMO Market Forecast, by Product
12.9 Rest of Latin America CMO Market Attractiveness Analysis, by Product, 2015
12.10 Market Trends

Section 13 Company Profiles 
13.1 Competition Matrix 
13.2 BASF SE 
    13.2.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.2.2 Financial Overview
    13.2.3 Product Portfolio
    13.2.4 SWOT Analysis
    13.2.5 Strategic Overview
13.3 Bayer AG 
    13.3.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.3.2 Financial Overview
    13.3.3 Product Portfolio
    13.3.4 SWOT Analysis
    13.3.5 Strategic Overview
13.4 Boehringer Ingelheim GmbH 
    13.4.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.4.2 Financial Overview
    13.4.3 Product Portfolio
    13.4.4 SWOT Analysis
    13.4.5 Strategic Overview
13.5 F. Hoffmann-La Roche Ltd.
    13.5.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.5.2 Financial Overview
    13.5.3 Product Portfolio
    13.5.4 SWOT Analysis
    13.5.5 Strategic Overview
13.6 Merck & Co., Inc.
    13.6.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.6.2 Financial Overview
    13.6.3 Product Portfolio
    13.6.4 SWOT Analysis
    13.6.5 Strategic Overview
13.7 Novartis AG
    13.7.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.7.2 Financial Overview
    13.7.3 Product Portfolio
    13.7.4 SWOT Analysis
    13.7.5 Strategic Overview
13.8 Pfizer, Inc.
    13.8.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.8.2 Financial Overview
    13.8.3 Product Portfolio
    13.8.4 SWOT Analysis
    13.8.5 Strategic Overview
13.9 Pisa Farmacéutica 
    13.9.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.9.2 Financial Overview
    13.9.3 Product Portfolio
    13.9.4 SWOT Analysis
    13.9.5 Strategic Overview
13.10 Fresenius SE & Co. KGaA 
    13.10.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.10.2 Financial Overview
    13.10.3 Product Portfolio
    13.10.4 SWOT Analysis
    13.10.5 Strategic Overview
13.11 Takeda Pharmaceutical Company Limited 
    13.11.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.11.2 Financial Overview
    13.11.3 Product Portfolio
    13.11.4 SWOT Analysis
    13.11.5 Strategic Overview
13.12 Ferring Pharmaceuticals, Inc. 
    13.12.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.12.2 Financial Overview
    13.12.3 Product Portfolio
    13.12.4 SWOT Analysis
    13.12.5 Strategic Overview
13.13 Landsteiner Scientific 
    13.13.1 Company Overview (HQ, Business Segments, Employee Strength)
    13.13.2 Financial Overview
    13.13.3 Product Portfolio
    13.13.4 SWOT Analysis
    13.13.5 Strategic Overview

List of Figures
  
FIG. 1 LATAM Pharmaceutical Products Market Value Share Analysis, by Product Type, 2015 and 2024
FIG. 2 LATAM API and Ingredients Market Revenue (US$ Mn), 2014–2024
FIG. 3 LATAM Finished Dosage Form Market Revenue (US$ Mn), 2014–2024
FIG. 4 LATAM Pharmaceutical Packaging Market Revenue (US$ Mn), 2014–2024
FIG. 5 LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product Type
FIG. 6 LATAM CMO Market Value Share Analysis By Product Type, 2015 and 2024
FIG. 7 LATAM API and Ingredients Market Revenue (US$ Mn), 2014–2024
FIG. 8 LATAM API and Ingredients Market Revenue (US$ Mn), 2014–2024
FIG. 9 LATAM Pharmaceutical Packaging Market Revenue (US$ Mn), 2014–2024
FIG. 10 LATAM CMO Market Attractiveness Analysis, by Product Type
FIG. 11 Latin America Pharmaceutical Products Market Value Share Analysis, by Country, 2015 and 2024
FIG. 12 Pharmaceutical Products Market Attractiveness Analysis, by Country, 2015
FIG. 13 Latin America Market Value Share Analysis,
FIG. 14 Mexico Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 15 Mexico Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 16 Mexico Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 17 Mexico CMO Market Size (US$ Mn) Forecast, 2014–2024
FIG. 18 Mexico CMO Market Attractiveness Analysis, by Product 
FIG. 19 Mexico CMO Market Value Share Analysis, by Product, 2015 and 2024
FIG. 20 Mexico CMO Market Attractiveness Analysis, By Product, 2015
FIG. 21 Brazil Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 22 Brazil Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 23 Brazil Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 24 Brazil CMO Market Size (US$ Mn) Forecast, 2016–2024
FIG. 25 Brazil CMO Market Value Share Analysis, by Product, 2015 and 2024
FIG. 26 Brazil Market Attractiveness Analysis, by Product, 2015
FIG. 27 Venezuela Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 28 Venezuela Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 29 Venezuela Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 30 Venezuela CMO Market Size (US$ Mn) Forecast, 2016–2024
FIG. 31 Venezuela CMO Market Value Share Analysis, by Product, 2015 and 2024
FIG. 32 Venezuela CMO Market Attractiveness Analysis, by Product, 2015 and 2024
FIG. 33 Argentina Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 34 Argentina Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 35 Argentina Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 36 Argentina CMO Market Size (US$ Mn) Forecast, 2016–2024
FIG. 37 Argentina CMO Market Value Share Analysis,
FIG. 38 Argentina Market Attractiveness Analysis, by Product, 2015
FIG. 39 Rest of LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, 2014–2024
FIG. 40 Rest of LATAM Pharmaceutical Products Market Value Share Analysis, by Product, 2015 and 2024
FIG. 41 Rest of LATAM Pharmaceutical Products Market Attractiveness Analysis, by Product, 2015
FIG. 42 Rest of LATAM CMO Market Value Share Analysis,
FIG. 43 Rest of LATAM Market Attractiveness Analysis, by Product, 2015

 

List of Tables
  
TABLE 1 LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 2 LATAM CMO Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
TABLE 3 Latin America Pharmaceutical Products Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 4 Latin America Pharmaceutical Products Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 5 Mexico Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 6 Mexico CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 7 Brazil Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 8 Brazil CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 9 Venezuela Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 10 Venezuela CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 11 Argentina Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 12 Argentina CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024
TABLE 13 Rest of LATAM Pharmaceutical Products Market Size (US$ Mn) Forecast, by Product, 2014–2024
TABLE 14 Rest of LATAM CMO Market Size (US$ Mn) Forecast, by Product, 2016–2024

 


 
 
Back To Top